Cultivated Oral Mucosa Epithelium in Ocular Surface Reconstruction in Aniridia Patients

Table 1

Overview of aniridia patients data.

Case	Age	Gender	Eye	BCVA; pre	BCVA; post	Epithelial regularity	Follow-up (m.)	Treatment
1	28	F	R	CF	0.05	+++	18	Routine
2	28	F	L	0.05	0.1	+++	12	Routine
3	27	F	R	0.02	0.1	+++	14	Routine
4	54	F	R	HM	CF	+	13	Routine, PSED, DEX
5	26	F	L	0.02	0.05	+++	18	Routine
6	29	F	R	0.05	0.05	+++	18	Routine
7	27	F	L	0.01	0.03	+	17	Routine, PSED, DEX
8	18	F	L	HM	0.1	+++	18	Routine
9	18	F	R	HM	0.05	+++	14	Routine
10	49	M	L	CF	0.1	+++	18	Routine
11	40	F	R	CF	0.05	+++	15	Routine, TSED
12	23	M	L	HM	CF	+++	18	Routine, TSED
13	38	F	L	0.01	0.02	+++	18	Routine
14	38	F	R	HM	0.05	++	15	Routine, PSED
15	49	M	L	CF	0.1	+++	12	Routine
16	16	F	L	HM	HM	+++	18	Routine, TSED
17	22	F	R	HM	0.05	+	16	Routine, PSED, DEX

Fluorescein staining: absent (+++), local defects (++), and present (+).
CF: counting fingers and HM: hand movements.
Routine treatment: Levofloxacin and dexamethasone eye drops 5 times a day for a 2-week period and then only dexamethasone 3 times a day for the next 6 weeks.
Additional treatment: PSED: permanent serum eye drops, TSED: temporary serum eye drops, and DEX: additional dexamethasone administration over 2nd month from surgery.